Robots Accelerate Antibiotic Discovery, Producing 700 Compounds in Days

Researchers have leveraged robotic technology to dramatically speed up the discovery of antibiotics, creating over 700 metal compounds in just one week. This groundbreaking approach has unveiled a promising new antibiotic candidate aimed at combating the growing threat of drug-resistant bacteria.

The study, conducted by a team led by Dr. Angelo Frei at the University of York, highlights a significant advancement in automated chemistry. In an era where antimicrobial resistance increasingly jeopardizes public health—claiming more than one million lives annually worldwide—this innovative method offers a potential solution to a pressing global issue.

Transforming Antibiotic Discovery

As traditional antibiotic discovery methods become slower and more costly, the research team shifted their focus from conventional drug classes to metal-based compounds. Historically overlooked due to concerns about toxicity and complexity, these compounds present new avenues for effective treatments.

Using a robotic synthesis platform, the team combined nearly 200 different ligands with five metals through a technique known as “click” chemistry. This approach allowed them to create a diverse array of metal complexes in record time. Postdoctoral researcher Dr. David Husbands played a key role in this process, demonstrating how automation can transform drug discovery.

Traditional antibiotic development pipelines are often lengthy and unattractive to pharmaceutical companies. The researchers argue that automation not only expedites the discovery process but also broadens the chemical space explored, potentially leading to more effective treatments.

Promising New Antibiotic Candidate

After synthesizing the compounds, the team screened the entire library for antibacterial properties. Six candidates emerged as potential leads, with one iridium-based complex standing out due to its strong antibacterial activity against strains akin to MRSA. Importantly, this compound showed non-toxicity to human cells, suggesting a high therapeutic index that merits further investigation.

This discovery underscores a pivotal shift in antibiotic development, as metal complexes can interact with bacteria in novel ways, potentially overcoming existing resistance mechanisms. Dr. Frei emphasized the urgent need for new antibiotics, stating, “The pipeline for new antibiotics has been running dry for decades. We have to think differently.”

The findings, published in Nature Communications, indicate that combining smart “click” chemistry with advanced robotics enables researchers to explore vast and previously untapped areas of chemical space at unprecedented speeds.

Moreover, data from the Community for Open Antimicrobial Drug Discovery suggests that metal complexes may exhibit a higher “hit rate” for antibacterial activity without the toxicity often associated with standard organic molecules.

The implications of this research extend beyond antibiotic discovery. The same robotic synthesis platform could be adapted for identifying new catalysts in various industrial processes, potentially revolutionizing multiple fields of science.

Moving forward, the team plans to investigate the mechanisms by which the iridium compound attacks bacteria and aims to expand their robotic system to explore additional metals and applications, positioning themselves at the forefront of innovative drug discovery.